{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT04215991",
            "orgStudyIdInfo": {
                "id": "1704R2133"
            },
            "secondaryIdInfos": [
                {
                    "id": "2019-002121-30",
                    "type": "EUDRACT_NUMBER"
                }
            ],
            "organization": {
                "fullName": "Shionogi Inc.",
                "class": "INDUSTRY"
            },
            "briefTitle": "A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Cefiderocol in Hospitalized Pediatric Participants",
            "officialTitle": "An Open-label Study With a Nonrandomized Single-dose Phase in Subjects With Suspected or Confirmed Aerobic Gram-negative Bacterial Infections Followed by a Randomized, Multiple-dose, Active-controlled Phase in Subjects With Suspected or Confirmed Complicated Urinary Tract Infection (cUTI), Hospital-acquired Bacterial Pneumonia (HABP) or Ventilator-associated Bacterial Pneumonia (VABP) to Assess the Safety, Tolerability, and Pharmacokinetics of Cefiderocol in Hospitalized Pediatric Subjects 3 Months to < 18 Years of Age",
            "therapeuticArea": [
                "Infectious Diseases"
            ],
            "study": "a-study-to-assess-the-safety-tolerability-and-pharmacokinetics-of-cefiderocol-in-hospitalized-pediatric-participants"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-06",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2020-02-19",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-09-30",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-09-30",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2019-12-29",
            "studyFirstSubmitQcDate": "2019-12-29",
            "studyFirstPostDateStruct": {
                "date": "2020-01-02",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-06-04",
            "lastUpdatePostDateStruct": {
                "date": "2024-06-05",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Shionogi",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The primary objectives of this study are to assess the safety, tolerability, and pharmacokinetics (PK) of cefiderocol after single-dose administration in hospitalized pediatric participants 3 months to \\< 12 years of age with suspected or confirmed aerobic Gram-negative bacterial infections and after multiple-dose administration in hospitalized pediatric participants 3 months to \\< 18 years of age with suspected or confirmed complicated urinary tract infection (cUTI), hospital-acquired bacterial pneumonia (HABP), or ventilator-associated bacterial pneumonia (VABP).",
            "detailedDescription": "This study consists of a nonrandomized single-dose phase in children aged 3 months to less than 12 years with suspected or confirmed aerobic Gram-negative bacterial infections and a randomized multiple-dose, active-comparator standard of care (SOC) phase in children aged 3 months to less than 18 years with cUTI, HABP, or VABP to assess the PK, safety, and tolerability of cefiderocol in hospitalized participants requiring systemic antibiotics for an expected 5 to 14 days."
        },
        "conditionsModule": {
            "conditions": [
                "Gram-negative Bacterial Infections",
                "Hospital Acquired Bacterial Pneumonia (HABP)",
                "Complicated Urinary Tract Infection (cUTI)",
                "Ventilator Associated Bacterial Pneumonia (VABP)"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 85,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Single Dose Phase: Cefiderocol",
                    "type": "EXPERIMENTAL",
                    "description": "Participants will receive a single dose of cefiderocol administered intravenously (IV) on Day 1, in addition to standard of care. Participants weighing less than 34 kilograms (kg) will receive 60 milligrams (mg)/kg cefiderocol and participants \u226534 kg will receive 2000 mg.",
                    "interventionNames": [
                        "Drug: Cefiderocol",
                        "Drug: Standard of Care"
                    ]
                },
                {
                    "label": "Multiple Dose Phase: Cefiderocol",
                    "type": "EXPERIMENTAL",
                    "description": "Participants will receive cefiderocol administered via IV every 8 hours for an expected 5 to 14 days in addition to standard of care. Participants weighing less than 34 kg will receive 60 mg/kg cefiderocol and participants \u2265 34 kg will receive 2000 mg. Dosage may be adjusted based on renal function.",
                    "interventionNames": [
                        "Drug: Cefiderocol",
                        "Drug: Standard of Care"
                    ]
                },
                {
                    "label": "Multiple Dose Phase: Standard of Care Alone",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "Participants will receive standard of care treatment according to local standards.",
                    "interventionNames": [
                        "Drug: Standard of Care"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Cefiderocol",
                    "description": "Administered intravenously over 3 hours",
                    "armGroupLabels": [
                        "Multiple Dose Phase: Cefiderocol",
                        "Single Dose Phase: Cefiderocol"
                    ],
                    "otherNames": [
                        "Fetroja",
                        "S-649266"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Standard of Care",
                    "description": "Standard of care administered will be selected by the investigator based on the suspected or confirmed pathogen(s) for the infection in accordance with local standards.",
                    "armGroupLabels": [
                        "Multiple Dose Phase: Cefiderocol",
                        "Multiple Dose Phase: Standard of Care Alone",
                        "Single Dose Phase: Cefiderocol"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Number of Participants with Adverse Events in the Single Dose Phase",
                    "timeFrame": "28 days"
                },
                {
                    "measure": "Maximum Observed Plasma Concentration (Cmax) of Cefiderocol in the Single Dose Phase",
                    "timeFrame": "Day 1, 1 (cohort 2 only), 3, 3.5 (cohort 2 only), 5, and 8 hours after the start of infusion"
                },
                {
                    "measure": "Area Under the Plasma Concentration Time Curve Extrapolated from Time 0 to Infinity (AUCinf) of Cefiderocol in the Single Dose Phase",
                    "timeFrame": "Day 1, 1 (cohort 2 only), 3, 3.5 (cohort 2 only), 5, and 8 hours after the start of infusion"
                },
                {
                    "measure": "Apparent Terminal Elimination Half-life of Cefiderocol in the Single Dose Phase",
                    "timeFrame": "Day 1, 1 (cohort 2 only), 3, 3.5 (cohort 2 only), 5, and 8 hours after the start of infusion"
                },
                {
                    "measure": "Number of Participants with Adverse Events in the Multiple Dose Phase",
                    "timeFrame": "Up to 28 days after last dose (33 to 42 days depending on treatment duration)"
                },
                {
                    "measure": "Maximum Observed Plasma Concentration of Cefiderocol in the Multiple Dose Phase",
                    "timeFrame": "During one of the dosing intervals from Day 5-14, 1 (cohort 2 1 and 2 only), 3, 3.5 (cohorts 1 and 2 only), 5, and 8 hours after the start of infusion"
                },
                {
                    "measure": "Area Under the Plasma Concentration Time Curve Over the Dosing Interval \u03c4 (AUC0-\u03c4) of Cefiderocol in the Multiple Dose Phase",
                    "timeFrame": "During one of the dosing intervals from Day 5-14, 1 (cohort 2 1 and 2 only), 3, 3.5 (cohorts 1 and 2 only), 5, and 8 hours after the start of infusion"
                },
                {
                    "measure": "Apparent Terminal Elimination Half-life of Cefiderocol in the Multiple Dose Phase",
                    "timeFrame": "During one of the dosing intervals from Day 5-14, 1 (cohort 2 1 and 2 only), 3, 3.5 (cohorts 1 and 2 only), 5, and 8 hours after the start of infusion"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n1. Participant's parent(s) or legally authorized representative(s) (LAR) provides written informed consent in accordance with regional- and country-specific laws and regulations\n2. Participant provides written informed assent, when feasible (age of assent to be determined by institutional review board/independent ethics committee \\[IRBs/IECs\\] or be consistent with local legal requirements)\n3. Hospitalized participant is 3 months to \\< 18 years of age at the time written informed consent/assent is obtained for the multiple-dose phase. Hospitalized participant is 3 months to \\< 12 years of age at the time written informed consent/assent is obtained for the single-dose phase.\n4. Single-dose phase: Participant has a suspected or confirmed infection type (including but not limited to cUTI, complicated intra-abdominal infections \\[cIAI\\], pneumonia, HABP/VABP, and sepsis or bloodstream infections \\[BSI\\]) that requires hospitalization for treatment with IV antibiotics.\n\n   Multiple-dose phase: Participant has a suspected or confirmed cUTI, HABP, or VABP that requires hospitalization for treatment with IV antibiotics\n5. If participant is a sexually active female of childbearing potential and has reached menarche or Tanner stage 3, participant agrees to use barrier contraception (including condom, diaphragm, or cervical cap) with spermicide or agrees to use a highly effective method of contraception (including contraceptive implant, injectable contraceptive, combination oral contraceptive, or an intrauterine \\[IUD\\] contraceptive device) from Screening up to 28 days after administration of the last dose of cefiderocol.\n\nExclusion Criteria:\n\n1. Participant has a documented history of any hypersensitivity or allergic reaction to any \u03b2-lactam antibiotic (Note: for \u03b2-lactams, a history of a mild rash followed by uneventful re-exposure is not a contraindication to enrollment.)\n2. Multiple-dose only: Participant has an infection caused only by a confirmed Gram-positive pathogen.\n3. Participant has a suspected or confirmed central nervous system (CNS) infection (for example, meningitis, brain abscess, shunt infection) or osteomyelitis (which would require prolonged antibiotic therapy).\n4. Participant has cystic fibrosis.\n5. Single-dose phase: Participant has moderate or severe renal impairment based on estimated glomerular filtration rate (eGFR) (based on the Schwartz equation if \u2265 3 months to \\< 1 year of age and modified Bedside Schwartz equation if \u2265 1 to \\< 18 years of age) of \\< 60 milliliter (mL)/ minute (min)/1.73 square meters (m\\^2)\u00b2 at Screening .\n\n   Multiple-dose phase: Participant has an eGFR (based on the Schwartz equation if \u2265 3 months to \\< 1 year of age and modified Bedside Schwartz equation if \u2265 1 to \\< 18 years of age) of \\< 15 mL/min/1.73 m\u00b2 at Screening.\n6. Participant has end-stage renal disease (ESRD), is on hemodialysis (HD), or receiving continuous venovenous hemofiltration (CVVH).\n7. Participant has experienced shock in the prior month or is in shock at the time of Screening.\n8. Participant has severe neutropenia or is severely immunocompromised.\n9. Participant has multiorgan failure .\n10. Participant with a life expectancy of \\< 30 days due to severity of a concurrent illness.\n11. Participant is a female who has a positive pregnancy test at Screening.\n12. Participant is a female who is breastfeeding.\n13. Participant has received any other investigational medicinal product (IMP) within 30 days.\n14. Participant has any condition or circumstance that, in the opinion of the investigator, would compromise the safety of the participant or the quality of the study data, including acute trauma to the pelvis or urinary tract.\n15. Participant is receiving vasopressor therapy at Screening.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "3 Months",
            "maximumAge": "17 Years",
            "stdAges": [
                "CHILD"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Shionogi Clinical Trials Administrator Clinical Support Help Line",
                    "role": "CONTACT",
                    "phone": "800-849-9707",
                    "email": "Shionogiclintrials-admin@shionogi.co.jp"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Shionogi Clinical Trials Administrator Clinical Support Help Line",
                    "affiliation": "Shionogi",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "Cook Children's Medical Center",
                    "status": "TERMINATED",
                    "city": "Fort Worth",
                    "state": "Texas",
                    "zip": "76104",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 32.72541,
                        "lon": -97.32085
                    }
                },
                {
                    "facility": "Queensland Children's Health Precinct Level 8, Centre for Children's Health Research 62 Graham Street",
                    "status": "RECRUITING",
                    "city": "South Brisbane",
                    "state": "Queensland",
                    "zip": "4101",
                    "country": "Australia",
                    "geoPoint": {
                        "lat": -27.48034,
                        "lon": 153.02049
                    }
                },
                {
                    "facility": "Heraklion University General Hospital",
                    "status": "TERMINATED",
                    "city": "Heraklion",
                    "state": "Crete",
                    "zip": "7110",
                    "country": "Greece",
                    "geoPoint": {
                        "lat": 35.32787,
                        "lon": 25.14341
                    }
                },
                {
                    "facility": "University General Hospital of Larissa",
                    "status": "RECRUITING",
                    "city": "Larissa",
                    "state": "Thessaly",
                    "zip": "41110",
                    "country": "Greece",
                    "geoPoint": {
                        "lat": 39.63689,
                        "lon": 22.41761
                    }
                },
                {
                    "facility": "University Hospital \"ATTIKON\" 3rd Pediatric Clinic of NKUA",
                    "status": "RECRUITING",
                    "city": "Chaidari",
                    "zip": "12462",
                    "country": "Greece",
                    "geoPoint": {
                        "lat": 38.01135,
                        "lon": 23.66597
                    }
                },
                {
                    "facility": "Hippokration Hospital 3rd Pediatric Clinic of AUTH Konstantinoupoleos 49",
                    "status": "RECRUITING",
                    "city": "Thessaloniki",
                    "zip": "54642",
                    "country": "Greece",
                    "geoPoint": {
                        "lat": 40.64361,
                        "lon": 22.93086
                    }
                },
                {
                    "facility": "General Hospital of Thessaloniki Papageorgiou",
                    "status": "RECRUITING",
                    "city": "Thessaloniki",
                    "zip": "56403",
                    "country": "Greece",
                    "geoPoint": {
                        "lat": 40.64361,
                        "lon": 22.93086
                    }
                },
                {
                    "facility": "Hospital of Lithuanian University of Health Sciences Kauno klinikos",
                    "status": "TERMINATED",
                    "city": "Kaunas",
                    "zip": "LT-50161",
                    "country": "Lithuania",
                    "geoPoint": {
                        "lat": 54.90272,
                        "lon": 23.90961
                    }
                },
                {
                    "facility": "Klaipeda Children's Hospital",
                    "status": "TERMINATED",
                    "city": "Klaipeda",
                    "zip": "LT-92140",
                    "country": "Lithuania",
                    "geoPoint": {
                        "lat": 55.70888,
                        "lon": 21.14311
                    }
                },
                {
                    "facility": "Vilnius University Hospital Santaros Klinikos",
                    "status": "RECRUITING",
                    "city": "Vilnius",
                    "zip": "LT-08406",
                    "country": "Lithuania",
                    "geoPoint": {
                        "lat": 54.68916,
                        "lon": 25.2798
                    }
                },
                {
                    "facility": "Hospital Civil de Guadalajara Hospital 278, El retiro, Torre Piso 10, Infectolog\u00eda Ped.",
                    "status": "RECRUITING",
                    "city": "Guadalajara",
                    "state": "Jalisco",
                    "zip": "44280",
                    "country": "Mexico",
                    "geoPoint": {
                        "lat": 20.66682,
                        "lon": -103.39182
                    }
                },
                {
                    "facility": "Instituto Nacional de Pediatr\u00eda \"Laboratorio de la Unidad de Apoyo a la Investigaci\u00f3n Cl\u00ednica\", Planta Baja Col. Insurgentes Cuicuilco, Delegacion Coyoac\u00e1n Av. Insurgentes Sur 3700-C",
                    "status": "RECRUITING",
                    "city": "Ciudad de M\u00e9xico",
                    "zip": "4530",
                    "country": "Mexico",
                    "geoPoint": {
                        "lat": 19.42847,
                        "lon": -99.12766
                    }
                },
                {
                    "facility": "Hospital de Especialidades Ped Via Espa\u00f1a y Calle Zarak",
                    "status": "TERMINATED",
                    "city": "Ciudad de Panama",
                    "zip": "0801",
                    "country": "Panama",
                    "geoPoint": {
                        "lat": 8.9936,
                        "lon": -79.51973
                    }
                },
                {
                    "facility": "Hospital del Ni\u00f1o, Epidemiologia",
                    "status": "RECRUITING",
                    "city": "Panama City",
                    "zip": "0816-00383",
                    "country": "Panama",
                    "geoPoint": {
                        "lat": 8.9936,
                        "lon": -79.51973
                    }
                },
                {
                    "facility": "Chong Hua Hospital",
                    "status": "RECRUITING",
                    "city": "Cebu City",
                    "zip": "6000",
                    "country": "Philippines",
                    "geoPoint": {
                        "lat": 10.31672,
                        "lon": 123.89071
                    }
                },
                {
                    "facility": "Western Visayas and Medical Center",
                    "status": "RECRUITING",
                    "city": "Iloilo City",
                    "zip": "5000",
                    "country": "Philippines",
                    "geoPoint": {
                        "lat": 10.69694,
                        "lon": 122.56444
                    }
                },
                {
                    "facility": "Manila Doctor's Hospital",
                    "status": "TERMINATED",
                    "city": "Manila",
                    "zip": "1000",
                    "country": "Philippines",
                    "geoPoint": {
                        "lat": 14.6042,
                        "lon": 120.9822
                    }
                },
                {
                    "facility": "Hospital Val d'Hebron",
                    "status": "RECRUITING",
                    "city": "Barcelona",
                    "zip": "08035",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 41.38879,
                        "lon": 2.15899
                    }
                },
                {
                    "facility": "Hospital del Mar, Passeig Mar\u00edtim 25-29",
                    "status": "TERMINATED",
                    "city": "Barcelona",
                    "zip": "8003",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 41.38879,
                        "lon": 2.15899
                    }
                },
                {
                    "facility": "Municipal Noncommercial Enterprise of Kharkiv Regional Council \" V.I.Shapoval Regional Clinical Center of Urology and Nephrology\", Department of Children Urology # 7",
                    "status": "ACTIVE_NOT_RECRUITING",
                    "city": "Kharkiv",
                    "zip": "61037",
                    "country": "Ukraine",
                    "geoPoint": {
                        "lat": 49.98081,
                        "lon": 36.25272
                    }
                },
                {
                    "facility": "Vinnytsia Regional Children's Hospital",
                    "status": "ACTIVE_NOT_RECRUITING",
                    "city": "Vinnytsia",
                    "zip": "21000",
                    "country": "Ukraine",
                    "geoPoint": {
                        "lat": 49.23278,
                        "lon": 28.48097
                    }
                },
                {
                    "facility": "Zaporizhzhia Regional Children Clinical Hospital",
                    "status": "ACTIVE_NOT_RECRUITING",
                    "city": "Zaporizhzhia",
                    "zip": "69063",
                    "country": "Ukraine",
                    "geoPoint": {
                        "lat": 50.60727,
                        "lon": 31.78792
                    }
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000007239",
                    "term": "Infections"
                },
                {
                    "id": "D000003141",
                    "term": "Communicable Diseases"
                },
                {
                    "id": "D000011014",
                    "term": "Pneumonia"
                },
                {
                    "id": "D000014552",
                    "term": "Urinary Tract Infections"
                },
                {
                    "id": "D000001424",
                    "term": "Bacterial Infections"
                },
                {
                    "id": "D000018410",
                    "term": "Pneumonia, Bacterial"
                },
                {
                    "id": "D000016905",
                    "term": "Gram-Negative Bacterial Infections"
                }
            ],
            "ancestors": [
                {
                    "id": "D000020969",
                    "term": "Disease Attributes"
                },
                {
                    "id": "D000010335",
                    "term": "Pathologic Processes"
                },
                {
                    "id": "D000012141",
                    "term": "Respiratory Tract Infections"
                },
                {
                    "id": "D000008171",
                    "term": "Lung Diseases"
                },
                {
                    "id": "D000012140",
                    "term": "Respiratory Tract Diseases"
                },
                {
                    "id": "D000014570",
                    "term": "Urologic Diseases"
                },
                {
                    "id": "D000052776",
                    "term": "Female Urogenital Diseases"
                },
                {
                    "id": "D000005261",
                    "term": "Female Urogenital Diseases and Pregnancy Complications"
                },
                {
                    "id": "D000091642",
                    "term": "Urogenital Diseases"
                },
                {
                    "id": "D000052801",
                    "term": "Male Urogenital Diseases"
                },
                {
                    "id": "D000001423",
                    "term": "Bacterial Infections and Mycoses"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M10283",
                    "name": "Infections",
                    "asFound": "Infection",
                    "relevance": "HIGH"
                },
                {
                    "id": "M6368",
                    "name": "Communicable Diseases",
                    "asFound": "Infection",
                    "relevance": "HIGH"
                },
                {
                    "id": "M13904",
                    "name": "Pneumonia",
                    "asFound": "Pneumonia",
                    "relevance": "HIGH"
                },
                {
                    "id": "M17302",
                    "name": "Urinary Tract Infections",
                    "asFound": "Urinary Tract Infections",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4722",
                    "name": "Bacterial Infections",
                    "asFound": "Bacterial Infections",
                    "relevance": "HIGH"
                },
                {
                    "id": "M19249",
                    "name": "Gram-Negative Bacterial Infections",
                    "asFound": "Gram-Negative Bacterial Infections",
                    "relevance": "HIGH"
                },
                {
                    "id": "M20529",
                    "name": "Pneumonia, Bacterial",
                    "asFound": "Bacterial Pneumonia",
                    "relevance": "HIGH"
                },
                {
                    "id": "M22700",
                    "name": "Disease Attributes",
                    "relevance": "LOW"
                },
                {
                    "id": "M14978",
                    "name": "Respiratory Tract Infections",
                    "relevance": "LOW"
                },
                {
                    "id": "M11168",
                    "name": "Lung Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14977",
                    "name": "Respiratory Tract Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M17319",
                    "name": "Urologic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M2875",
                    "name": "Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M27093",
                    "name": "Female Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14127",
                    "name": "Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M8399",
                    "name": "Female Urogenital Diseases and Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M27095",
                    "name": "Male Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M12136",
                    "name": "Mycoses",
                    "relevance": "LOW"
                },
                {
                    "id": "M4721",
                    "name": "Bacterial Infections and Mycoses",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC01",
                    "name": "Infections"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "BC08",
                    "name": "Respiratory Tract (Lung and Bronchial) Diseases"
                },
                {
                    "abbrev": "BXS",
                    "name": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000097602",
                    "term": "Cefiderocol"
                }
            ],
            "ancestors": [
                {
                    "id": "D000017262",
                    "term": "Siderophores"
                },
                {
                    "id": "D000007502",
                    "term": "Iron Chelating Agents"
                },
                {
                    "id": "D000002614",
                    "term": "Chelating Agents"
                },
                {
                    "id": "D000064449",
                    "term": "Sequestering Agents"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000097902",
                    "term": "Beta Lactam Antibiotics"
                },
                {
                    "id": "D000000900",
                    "term": "Anti-Bacterial Agents"
                },
                {
                    "id": "D000000890",
                    "term": "Anti-Infective Agents"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M3356",
                    "name": "Cefiderocol",
                    "asFound": "Twin Pregnancies",
                    "relevance": "HIGH"
                },
                {
                    "id": "M10533",
                    "name": "Iron",
                    "relevance": "LOW"
                },
                {
                    "id": "M5860",
                    "name": "Chelating Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M10534",
                    "name": "Iron Chelating Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M4222",
                    "name": "Anti-Bacterial Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M4224",
                    "name": "Antibiotics, Antitubercular",
                    "relevance": "LOW"
                },
                {
                    "id": "M10789",
                    "name": "Lactams",
                    "relevance": "LOW"
                },
                {
                    "id": "M25772",
                    "name": "beta-Lactams",
                    "relevance": "LOW"
                },
                {
                    "id": "M3444",
                    "name": "Beta Lactam Antibiotics",
                    "relevance": "LOW"
                },
                {
                    "id": "M4214",
                    "name": "Anti-Infective Agents",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Infe",
                    "name": "Anti-Infective Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "Micro",
                    "name": "Micronutrients"
                }
            ]
        }
    },
    "hasResults": false
}